Close
Christine Mikail, J.D.

Christine Mikail, J.D., President

Ms. Mikail has almost two decades of experience supporting biotechnology and pharmaceutical companies in legal, business development, operations and finance capacities. Most recently, she co-founded Neumentum, Inc., a neurology specialty pharma company, and Ferndale Advisors, a consulting firm advising small and midsize biotech companies. During her time at Ferndale Advisors, Ms. Mikail co-founded two start-up companies, led various transformational business development and financing transactions and assisted in raising more than $50 million. Before founding Ferndale Advisors, Ms. Mikail was Chief Administrative Officer and Head of External Business Development/Alliance Management & General Counsel at Axovant Sciences, Inc., where she was an integral member of the team that raised $362 million in the company’s IPO. Prior to joining Axovant, Ms. Mikail held a variety of senior positions at NPS Pharmaceuticals, Inc., Dendreon Corporation, Eli Lilly and Company and ImClone Systems. Ms. Mikail developed her life sciences focus as a corporate and securities lawyer at Reed Smith and WilmerHale. Ms. Mikail graduated cum laude with a B.A. from Rutgers University, Rutgers College, New Brunswick, NJ, and earned a J.D. from Fordham University, School of Law, New York, NY.